Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
GenMark Diagnostics, Inc. (GNMK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/18/2021 |
GN
| STOCK ALERT: Halper Sadeh LLP Investigates RMBL, STAY, GNMK, TPCO; Shareholders Are Encouraged to Contact the Firm |
| 03/15/2021 |
GN
| SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GenMark Diagnostics, Inc. Buyout |
| 03/15/2021 |
GN
| GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. |
| 02/22/2021 |
GN
| GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis |
| 02/16/2021 |
GN
| GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference |
| 02/11/2021 |
GN
| GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 |
| 01/11/2021 |
GN
| GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020 |
| 12/28/2020 |
GN
| GenMark Diagnostics to Participate in Upcoming Investor Conferences |
| 10/14/2020 |
GN
| GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020 |
| 10/08/2020 |
GN
| GenMark Diagnostics' ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA |
| 10/08/2020 |
GN
| GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020 |
| 09/15/2020 |
GN
| Le Panel de pathogènes respiratoires 2 (RP2) ePlex de GenMark Diagnostics obtient le marquage CE |
| 09/14/2020 |
GN
| GenMark Diagnostics' ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE Mark |
| 08/17/2020 |
GN
| GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test |
| 08/04/2020 |
GN
| GenMark Diagnostics Reports Second Quarter 2020 Results |
| 07/29/2020 |
GN
| GenMark Diagnostics to Participate in Upcoming Investor Conferences |
| 07/21/2020 |
GN
| GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020 |
| 07/07/2020 |
GN
| GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020 |
| 06/29/2020 |
GN
| GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2) |
| 05/27/2020 |
GN
| GenMark Diagnostics to Participate in Upcoming Investor Conferences |
| 05/06/2020 |
GN
| GenMark Prices Public Offering of Common Stock |
| 04/22/2020 |
GN
| GenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020 |
| 04/07/2020 |
GN
| GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance |
| 03/23/2020 |
GN
| GenMark Awarded BARDA Grant for the Development of ePlex® RP2 Panel |
| 03/19/2020 |
GN
| GenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 Test |
| 03/02/2020 |
GN
| GenMark Diagnostics Reports Fourth Quarter and Full Year 2019 Results |
| 02/18/2020 |
GN
| GenMark Diagnostics to Participate in the Cowen Health Care Conference |
| 01/13/2020 |
GN
| GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019 |
| 08/05/2019 |
GN
| GenMark Diagnostics Reports Second Quarter 2019 Results |
| 07/22/2019 |
GN
| GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019 |
| 05/01/2019 |
GN
| GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference |
| 04/15/2019 |
GN
| GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019 |
| 04/15/2019 |
GN
| GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel |
| 02/21/2019 |
GN
| GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results |
|
|
|